Security
Myomo Inc. · MYO
MYONYSE_AMERICANCommon stockCurrentCIK 1369290Updated Oct 16, 2026
Name history
MYOMO INC · through Feb 24, 2020
MYO price & chart
Loading TradingView…
AMEX:MYO on TradingView ↗About the company
Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. Myomo develops and markets the MyoPro product line. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. It is currently the only marketed device in the U.S. that, sensing a patient’s own EMG signals through non-invasive sensors on the arm, can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. Many are able to return to work, live independently and reduce their cost of care. Myomo is headquartered in Burlington, Massachusetts, with sales and clinical professionals across the U.S. and representatives internationally. For more information, please visit www.myomo.com.
In the news
No coverage from other publishers is available.
Recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 34,077,430Source | 16,312,871Source | 35,342,254Source | 38,672,347Source | 16,190,381Source | 36,753,687Source | 40,867,327Source | 16,520,857Source | 38,636,573Source | 42,244,079Source | 14,581,568Source | 10,162,006Source |
| Property, Plant and Equipment, NetUSD | 3,714,810Source | 561,325Source | 1,986,836Source | 2,908,804Source | 289,303Source | 2,242,811Source | 1,842,254Source | 205,917Source | 2,212,901Source | 1,330,008Source | 175,794Source | 194,283Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 12,553,558Source | 6,622,675Source | 11,219,217Source | 14,240,432Source | 5,846,100Source | 11,396,426Source | 19,793,799Source | 5,434,726Source | 14,132,027Source | 24,372,373Source | 6,871,306Source | 5,345,967Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 5,292,520Source | 3,729,387Source | 4,945,509Source | 7,054,545Source | 2,526,361Source | 4,824,537Source | 4,663,398Source | 1,683,414Source | 4,096,327Source | 3,825,291Source | 2,382,658Source | 1,896,163Source |
| Inventory, NetUSD | 3,645,314Source | 3,383,513Source | 3,169,372Source | 4,125,597Source | 2,601,104Source | 3,548,424Source | 3,368,502Source | 2,386,497Source | 3,123,089Source | 3,165,965Source | 1,803,507Source | 1,399,865Source |
| Assets, CurrentUSD | 22,948,987Source | 14,704,144Source | 24,525,681Source | 28,043,810Source | 15,141,689Source | 25,657,818Source | 31,097,277Source | 15,705,088Source | 27,557,085Source | 32,789,996Source | 13,650,983Source | 9,215,457Source |
| Prepaid Expense and Other Assets, CurrentUSD | 1,457,595Source | 968,569Source | 2,958,442Source | 1,381,721Source | 1,032,323Source | 1,588,453Source | 1,541,118Source | 676,787Source | 1,943,860Source | 933,377Source | 598,850Source | 573,462Source |
| Operating Lease, Right-of-Use AssetUSD | 6,870,283Source | 466,962Source | 6,514,020Source | 7,058,063Source | 539,498Source | 6,499,282Source | 7,295,711Source | 604,897Source | 6,679,349Source | 7,584,663Source | 663,554Source | 508,743Source |
| Other Assets, NoncurrentUSD | 168,350Source | 205,440Source | 19,185Source | 286,670Source | 219,891Source | 21,374Source | 257,085Source | 4,955Source | 21,374Source | 164,412Source | 91,237Source | 111,034Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 19,451,847Source | 7,020,537Source | 29,512,884Source | 21,057,219Source | 6,512,670Source | 27,752,006Source | 19,180,263Source | 5,621,100Source | 27,233,106Source | 17,530,022Source | 5,592,218Source | 3,802,641Source |
| Commitments and ContingenciesUSD | 0Source | 0Source | 0Source | — | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Stockholders’ equity: | ||||||||||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 3,843Source | 3,026Source | 3,953Source | 3,778Source | 3,021Source | 3,856Source | 3,446Source | 2,881Source | 3,847Source | 3,439Source | 2,715Source | 775Source |
| Retained Earnings (Accumulated Deficit)USD | -114,874,483Source | -102,854,457Source | -125,719,181Source | -111,211,568Source | -101,888,048Source | -121,697,821Source | -106,579,596Source | -100,766,441Source | -118,688,422Source | -103,114,538Source | -96,930,809Source | -88,783,244Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 137,653Source | 395,734Source | 224,976Source | 48,334Source | 138,888Source | 174,882Source | -116,545Source | 147,511Source | 164,517Source | -14,406Source | 83,669Source | 43,227Source |
| Stockholders' Equity Attributable to ParentUSD | 14,625,583Source | 9,292,334Source | 5,829,370Source | 17,615,128Source | 9,677,711Source | 9,001,681Source | 21,687,064Source | 10,899,757Source | 11,403,467Source | 24,714,057Source | 8,989,350Source | 6,359,365Source |
| Additional Paid in Capital, Common StockUSD | 129,365,034Source | 111,754,495Source | 131,326,086Source | 128,781,048Source | 111,430,314Source | 130,527,228Source | 128,386,223Source | 111,522,270Source | 129,929,989Source | 127,846,026Source | 105,840,239Source | 95,105,071Source |
| Liabilities and EquityUSD | 34,077,430Source | 16,312,871Source | 35,342,254Source | 38,672,347Source | 16,190,381Source | 36,753,687Source | 40,867,327Source | 16,520,857Source | 38,636,573Source | 42,244,079Source | 14,581,568Source | 10,162,006Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 9,202,458Source | 6,991,372Source | 10,610,121Source | 11,753,770Source | 6,465,332Source | 9,385,020Source | 11,675,269Source | 5,556,501Source | 8,345,329Source | 10,171,838Source | 5,477,058Source | 3,601,936Source |
| Operating Lease, Liability, CurrentUSD | 464,239Source | 205,464Source | 697,917Source | 460,351Source | 316,600Source | 594,937Source | 765,616Source | 421,514Source | 494,662Source | 748,021Source | 486,143Source | 353,701Source |
| Operating Lease, Liability, NoncurrentUSD | 7,832,722Source | 29,165Source | 7,206,046Source | 7,970,116Source | 47,338Source | 7,440,778Source | 7,504,994Source | 64,599Source | 7,665,622Source | 7,358,184Source | 115,160Source | 200,207Source |
| Additional Financial Items | ||||||||||||
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 12,553,600Source | — | 13,452,400Source | 15,482,000Source | — | — | — | — | 18,400,000Source | 24,900,000Source | — | — |
| Deferred Revenue, NoncurrentUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 498Source |
| Long-term DebtUSD | 2,416,667Source | — | 11,532,254Source | 1,333,333Source | — | 10,926,208Source | — | — | 11,222,155Source | — | — | — |
| Long-term Debt, Current MaturitiesUSD | 583,333Source | — | 446,962Source | 166,667Source | — | 2,733,243Source | — | — | 2,954,857Source | — | — | — |
| Short-term InvestmentsUSD | 0Source | 0Source | 2,233,141Source | 1,241,515Source | 3,135,801Source | 4,299,978Source | 4,299,978Source | 5,523,664Source | 4,261,782Source | 492,990Source | 1,994,662Source | — |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | -3,009,399Source | -3,465,058Source | -15,573,884Source | -6,183,729Source | -8,147,565Source | -10,721,022Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 597,248Source | 540,204Source | 2,084,042Source | 874,438Source | 1,115,602Source | 1,190,494Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | 691,038Source | 637,054Source | -376,966Source | 1,559,604Source | 495,599Source | -47,445Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 447,321Source | 550,772Source | 662,680Source | 1,395,042Source | 384,781Source | 607,400Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 0Source | — | — | — |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -2,197,336Source | -2,676,899Source | -14,511,454Source | -3,289,904Source | -6,172,764Source | -10,233,542Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -494,345Source | -1,896,098Source | -7,057,968Source | 259,981Source | -2,029,565Source | -310,793Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 327,807Source | 670,688Source | 1,742,247Source | 1,360,125Source | 145,816Source | 111,793Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 0Source | -36,506Source | 11,427,379Source | 20,932,429Source | 9,713,457Source | 376,858Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -2,735,601Source | -4,578,574Source | -10,040,346Source | 17,876,067Source | 1,525,339Source | -10,178,411Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 410,474Source | 111,865Source | 111,865Source | — | — | — |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 330,939Source | — | — | — |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 583,991Source | 324,185Source | 1,042,665Source | 394,889Source | 597,248Source | 540,204Source | 2,084,042Source | 874,438Source | 1,115,602Source | 1,190,494Source |
| Amortization of Debt Issuance CostsUSD | — | — | — | — | — | — | — | — | 215,000Source | — | — | — |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | — | — | 12,553,600Source | — | 13,452,400Source | 15,482,000Source | — | — | 18,400,000Source | 24,900,000Source | — | — |
| Debt and Equity Securities, Realized Gain (Loss)USD | — | — | — | — | — | — | — | — | — | 0Source | -169,503Source | -66,511Source |
| DepreciationUSD | — | — | — | — | — | — | — | 158,442Source | 859,354Source | 205,910Source | 164,306Source | 192,799Source |
| Equity Method Investment, Other than Temporary ImpairmentUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Gain (Loss) on Disposition of AssetsUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Gain (Loss) on InvestmentsUSD | — | — | — | — | — | — | — | — | — | — | — | -66,500Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | 0Source | — | — | 839,064Source | 0Source | -216,673Source | 0Source | -169,503Source | -66,511Source |
| General and Administrative ExpenseUSD | — | — | 3,177,856Source | 3,253,056Source | 3,712,481Source | 3,407,277Source | 3,618,739Source | 3,944,056Source | 13,961,235Source | 12,383,118Source | — | — |
| Income Tax Expense (Benefit)USD | — | — | 135,658Source | 84,876Source | 31,404Source | 148,201Source | 186,715Source | 136,795Source | 504,532Source | 365,617Source | 156,002Source | 69,937Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -3,662,915Source | -966,409Source | -4,021,360Source | -4,631,972Source | -3,009,399Source | -3,465,058Source | -15,573,884Source | -6,183,729Source | -8,147,565Source | -10,721,022Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | — | — | — | — | -10,721,022Source |
| Operating ExpensesUSD | — | — | 9,959,762Source | 7,903,108Source | 10,697,034Source | 10,642,493Source | 10,058,658Source | 10,129,884Source | 41,290,171Source | 29,392,041Source | 21,413,932Source | 20,925,300Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | — | 691,200Source | 582,700Source | 550,600Source | 557,500Source |
| Other Nonoperating Income (Expense)USD | — | — | -9,743Source | 76,020Source | -1,735,470Source | 106,549Source | 334,368Source | 191,991Source | -667,505Source | 388,586Source | 239,986Source | 21,119Source |
| Other Operating Income (Expense), NetUSD | — | — | — | 0Source | — | — | — | — | — | 0Source | -785Source | -1,101Source |
| Unrealized Gain (Loss) on DerivativesUSD | — | — | — | — | 409,000Source | — | 280,900Source | — | 81,000Source | — | — | — |
| Unrealized Gain (Loss) on InvestmentsUSD | — | — | — | 492Source | 5,523Source | 0Source | -3,398Source | 313Source | 922Source | -165Source | -757Source | — |
| Depreciation and amortization | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
| Payment, Tax Withholding, Share-based Payment Arrangement | — | — | — | — | —Source | — | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 10,090,699Source | 9,207,586Source | 11,704,565Source | 9,652,234Source | 10,113,288Source | 9,831,814Source | 40,928,042Source | 32,551,199Source | 19,241,158Source | 15,555,229Source |
| Cost of RevenueUSD | — | — | 97,500Source | 132,600Source | 72,900Source | 60,200Source | 59,600Source | 32,400Source | 109,000Source | 216,400Source | 6,058,775Source | 5,302,133Source |
| Selling, General and Administrative ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 18,777,445Source | 18,442,811Source |
| Operating Income (Loss)USD | — | — | -3,517,514Source | -957,553Source | -2,254,486Source | -4,590,320Source | -3,157,052Source | -3,520,254Source | -14,401,847Source | -6,206,698Source | -8,231,549Source | -10,672,204Source |
| Other Nonoperating Income (Expense)USD | — | — | -9,743Source | 76,020Source | -1,735,470Source | 106,549Source | 334,368Source | 191,991Source | -667,505Source | 388,586Source | 239,986Source | 21,119Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -3,527,257Source | -881,533Source | -3,989,956Source | -4,483,771Source | -2,822,684Source | -3,328,263Source | -15,069,352Source | -5,818,112Source | -7,991,563Source | -10,651,085Source |
| Income Tax Expense (Benefit)USD | — | — | 135,658Source | 84,876Source | 31,404Source | 148,201Source | 186,715Source | 136,795Source | 504,532Source | 365,617Source | 156,002Source | 69,937Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -3,662,915Source | -966,409Source | -4,021,360Source | -4,631,972Source | -3,009,399Source | -3,465,058Source | -15,573,884Source | -6,183,729Source | -8,147,565Source | -10,721,022Source |
| Earnings Per Share, BasicUSD per share | — | — | -0.09Source | -0.03Source | -0.09Source | -0.11Source | -0.07Source | -0.08Source | -0.37Source | -0.16Source | -0.28Source | -1.52Source |
| Earnings Per Share, DilutedUSD per share | — | — | -0.09Source | -0.03Source | -0.09Source | -0.11Source | -0.07Source | -0.08Source | -0.37Source | -0.16Source | -0.28Source | -1.52Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 42,168,120Source | 37,950,515Source | 42,697,319Source | 41,582,737Source | 42,269,133Source | 41,454,472Source | 41,855,607Source | 37,758,837Source | 29,499,341Source | 7,051,447Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 42,168,120Source | 37,950,515Source | 42,697,319Source | 41,582,737Source | 42,269,133Source | 41,454,472Source | 41,855,607Source | 37,758,837Source | 29,499,341Source | 7,051,447Source |
| Additional Financial Items | ||||||||||||
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 504,532Source | — | — | — |
| Debt and Equity Securities, Realized Gain (Loss)USD | — | — | — | — | — | — | — | — | — | 0Source | -169,503Source | -66,511Source |
| Gain (Loss) on InvestmentsUSD | — | — | — | — | — | — | — | — | — | — | — | -66,500Source |
| General and Administrative ExpenseUSD | — | — | 3,177,856Source | 3,253,056Source | 3,712,481Source | 3,407,277Source | 3,618,739Source | 3,944,056Source | 13,961,235Source | 12,383,118Source | — | — |
| Gross ProfitUSD | — | — | 6,442,248Source | 6,945,555Source | 8,442,548Source | 6,052,173Source | 6,901,606Source | 6,609,630Source | 26,888,324Source | 23,185,343Source | 13,182,383Source | 10,253,096Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -16,701,755Source | -6,824,771Source | -8,716,749Source | -10,831,796Source |
| Interest Income (Expense), Nonoperating, NetUSD | — | — | -9,743Source | 76,020Source | -535,744Source | 106,549Source | -504,696Source | 191,991Source | -450,832Source | 388,586Source | 410,274Source | 88,731Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | — | — | — | — | -10,721,022Source |
| Operating ExpensesUSD | — | — | 9,959,762Source | 7,903,108Source | 10,697,034Source | 10,642,493Source | 10,058,658Source | 10,129,884Source | 41,290,171Source | 29,392,041Source | 21,413,932Source | 20,925,300Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | — | 691,200Source | 582,700Source | 550,600Source | 557,500Source |
| Other Operating Income (Expense), NetUSD | — | — | — | 0Source | — | — | — | — | — | 0Source | -785Source | -1,101Source |
| Research and Development ExpenseUSD | — | — | 1,527,660Source | 1,248,870Source | 1,720,463Source | 2,001,331Source | 1,623,160Source | 1,790,024Source | 6,943,838Source | 4,772,013Source | 2,636,487Source | 2,482,489Source |
| Selling and Marketing ExpenseUSD | — | — | 5,254,246Source | 3,401,182Source | 5,264,090Source | 5,233,885Source | 4,816,759Source | 4,395,804Source | 20,385,098Source | 12,236,910Source | — | — |
| Depreciation, Depletion and Amortization, Nonproduction | — | — | — | — | — | — | —Source | —Source | — | — | — | — |
Filing attachments
myo-ex99_1.htm · S-8 · 2026-10-13
Exhibit 99.1 MYOMO, INC. RESTRICTED STOCK UNIT AWARD AGREEMENT (INDUCEMENT AWARD) Name of Grantee: ###PARTICIPANT_NAME### No. of Restricted Stock Units: ###TOTAL_AWARDS### Grant Date: ###GRANT_DATE### Myomo, Inc. (the “Company”) hereby grants an award of the number of Restricted Stock Units listed above (an “Award”) to the Grantee named above. Each Restricted Stock Unit shall relate to one share of Common Stock, par value $0.0001 per share (the “Stock”) of the Company. This Award is not is…
Read attachment ↗myo-ex99_2.htm · S-8 · 2026-10-13
Exhibit 99.2 MYOMO, INC. PERFORMANCE-BASED RESTRICTED STOCK UNIT AWARD AGREEMENT (INDUCEMENT AWARD) Name of Grantee: Target No. of Restricted Stock Units: the “Target Award”) Grant Date: Myomo, Inc. (the “Company”) hereby grants an award of the number of Restricted Stock Units listed above (an “Award”) to the Grantee named above. Each Restricted Stock Unit shall relate to one share of Common Stock, par value $0.0001 per share (the “Stock”) of the Company. This Award is not issued under the…
Read attachment ↗myo-ex99_1.htm · 8-K · 2026-08-05
EX-99.1 2 myo-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Myomo Reports Second Quarter 2026 Financial and Operating Results Revenue of $11.7 million, increased 21% year over year Four success pillars driving higher revenue growth and operating leverage Raising full year revenue guidance to $45-47 million Conference call begins at 4:30pm Eastern time today BURLINGTON, Mass. (August 5, 2026) - Myomo, Inc. (NYSE American: MYO)(“Myomo” or the “Company”), a wearable medical robotics platform c…
Read attachment ↗myo-ex99_1.htm · 8-K · 2026-05-13
Exhibit 99.1 Myomo Appoints Joseph M. Manko to its Board of Directors BURLINGTON, MA. (May 13, 2026) - Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Joseph M. (“Joe”) Manko Jr. as a director effective May 9, 2026, to serve until the 2027 annual meeting of stockholders. With this appointment, Myomo has…
Read attachment ↗myo-ex99_1.htm · 8-K · 2026-05-07
EX-99.1 2 myo-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Myomo Reports First Quarter 2026 Financial and Operating Results Revenue of $10.1 million with 49% of first quarter revenue from recurring patient sources MyoPro® orders received during the quarter were up 12% year-over-year Expanded gross margin, lower operating expenses and narrowed net loss Conference call begins at 4:30pm Eastern time today BURLINGTON, Mass. (May 7, 2026) - Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Comp…
Read attachment ↗myo-ex99_1.htm · 8-K · 2026-04-16
EX-99.1 2 myo-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Myomo Appoints William J Febbo to its Board of Directors BURLINGTON, MA. (April 16, 2026) - Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of William “Will” Febbo as a director effective April 14, 2026, to serve until the 2028 annual meeting of st…
Read attachment ↗